Russian scientists says EpiVacCorona effective against variants
Russia began mass trials of EpiVacCorona, which is being developed by Siberia's Vector Institute, in November last year
Russia began mass trials of EpiVacCorona, which is being developed by Siberia's Vector Institute, in November last year